Literature DB >> 9663626

The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health.

L O Gostin1.   

Abstract

This article examines the legal environment for programs to prevent transmission of HIV and other blood-borne diseases among injection drug users (IDUs). Cost-effective public health programs often have questionable legal authority, and health professionals, community activists, and IDUs may be subject to arrest and prosecution. Legal impediments to the sale and distribution of syringes exist in every state: 47 states have drug paraphernalia statutes, 8 states have syringe prescription statutes, and 23 states have pharmacy regulations or practice guidelines. The Mail Order Drug Paraphernalia Act permits federal enforcement against individuals who knowingly sell or distribute syringes to IDUs. Congress has prohibited the use of federal funds for syringe exchange programs (SEPs). Legal restrictions on access to sterile syringes present formidable obstacles to public health prevention. These restrictions render it much more difficult for pharmacists to sell syringes over the counter or for physicians to prescribe syringes, create a chilling effect on IDUs seeking to comply with medical advice and protect themselves and their partners from disease, and place significant obstacles on the lawful establishment and operation of SEPs. Public health authorities have only sometimes creatively circumvented legal restrictions through judicial declarations of lawfulness, municipal declarations of a "state of emergency," and by use of the "necessity" defense. I recommend repeal of syringe prescription statutes and reform of drug paraphernalia statutes and pharmacy regulations.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Year:  1998        PMID: 9663626     DOI: 10.1097/00042560-199802001-00012

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  11 in total

1.  Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?

Authors:  E Wood; M W Tyndall; P M Spittal; K Li; T Kerr; R S Hogg; J S Montaner; M V O'Shaughnessy; M T Schechter
Journal:  CMAJ       Date:  2001-08-21       Impact factor: 8.262

2.  Approval of syringe exchange programs in California: results from a local approach to HIV prevention.

Authors:  Ricky N Bluthenthal; Keith G Heinzerling; Rachel Anderson; Neil M Flynn; Alex H Kral
Journal:  Am J Public Health       Date:  2007-05-30       Impact factor: 9.308

3.  Reconciling incongruous qualitative and quantitative findings in mixed methods research: exemplars from research with drug using populations.

Authors:  Karla D Wagner; Peter J Davidson; Robin A Pollini; Steffanie A Strathdee; Rachel Washburn; Lawrence A Palinkas
Journal:  Int J Drug Policy       Date:  2011-06-15

Review 4.  Syringe availability as HIV prevention: a review of modalities.

Authors:  P Coffin
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

5.  A GIS-based methodology for improving needle exchange service delivery.

Authors:  Peter J Davidson; Shoshanna Scholar; Mary Howe
Journal:  Int J Drug Policy       Date:  2010-11-27

6.  State laws, syringe exchange, and HIV among persons who inject drugs in the United States: History and effectiveness.

Authors:  Heidi Bramson; Don C Des Jarlais; Kamyar Arasteh; Ann Nugent; Vivian Guardino; Jonathan Feelemyer; Derek Hodel
Journal:  J Public Health Policy       Date:  2015-01-15       Impact factor: 2.222

7.  Negotiating access: social barriers to purchasing syringes at pharmacies in Tijuana, Mexico.

Authors:  Peter J Davidson; Remedios Lozada; Perth C Rosen; Armando Macias; Manuel Gallardo; Robin A Pollini
Journal:  Int J Drug Policy       Date:  2012-06-05

8.  The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015.

Authors:  Tanner Nassau; Alia Al-Tayyib; William T Robinson; Jennifer Shinefeld; Kathleen A Brady
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

9.  Drug-related deaths and the sales of needles through pharmacies.

Authors:  Peter J Davidson; Alexis Martinez; Alexandra Lutnick; Alex H Kral; Ricky N Bluthenthal
Journal:  Drug Alcohol Depend       Date:  2014-12-02       Impact factor: 4.492

10.  A syringe prescription program to prevent infectious disease and improve health of injection drug users.

Authors:  Josiah D Rich; Michelle McKenzie; Grace E Macalino; Lynn E Taylor; Stephanie Sanford-Colby; Francis Wolf; Susan McNamara; Meenakshi Mehrotra; Michael D Stein
Journal:  J Urban Health       Date:  2004-03       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.